Chemours (NYSE:CC) reported quarterly earnings of $0.13 per share which missed the analyst consensus estimate of $0.21 by 38.1 percent. This is a 59.38 percent decrease over earnings of $0.32 per share from the same period last year. The company reported quarterly sales of $1.37 billion which beat the analyst consensus estimate of $1.35 billion by 1.18 percent. This is a 1.33 percent increase over sales of $1.35 billion the same period last year.